Examination of efficacy of olmesartan on peripheral insulin sensitivity in Japanese patients with type 2 diabetes
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Essential hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Dec 2011 Actual end date (Dec 2011) added as reported by University Hospital Medical Information Network - Japan.
- 03 Dec 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 10 May 2011 New trial record